Status | Study |
Completed |
Study Name: A Multicenter Study of the Efficacy of Cerezyme in Testing Skeletal Disease in Patients With Type I Gaucher Disease. Condition: Gaucher Disease Type I Cerebroside Lipidosis Syndrome Cluc Date: 2006-08-15 Interventions: Drug: Cerezyme (imiglucerase for injection) |
Completed |
Study Name: Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease Condition: Gaucher Disease, Type 1 Cerebroside Lipidosis Syndrome Glu Date: 2006-08-15 Interventions: Drug: Cerezyme Cerezyme doses of 20-60U/kg every 2 weeks (Q2 Arm) or 40-120 U/kg every 4 weeks (Q4 Arm). |
Completed |
Study Name: A Study of the Efficacy and Safety of Eliglustat Tartrate (Genz-112638) in Type 1 Gaucher Patients Condition: Gaucher Disease, Type 1 Cerebroside Lipidosis Syndrome Glu Date: 2006-07-27 Interventions: Drug: Eliglustat tartrate Eliglustat (Genz-112638) capsule as single 50 mg dose on Day 1 then eliglustat |
Recruiting |
Study Name: International Collaborative Gaucher Group (ICGG) Gaucher Registry Condition: Gaucher Disease Cerebroside Lipidosis Syndrome Glucocerebr Date: 2006-07-12 |
Completed |
Study Name: GTA-Glyceryltriacetate for Canavan Disease Condition: Infantile Canavan Disease Deficiency Disease, Aspartoacylase Date: 2006-01-15 Interventions: Drug: GTA: Glyceryltriacetate |
Completed |
Study Name: Safety and Effectiveness Study of rhGAA in Patients With Advanced Late-Onset Pompe Disease Receiving Respiratory Support Condition: Pompe Disease (Late-onset) Glycogen Storage Disease Type II (GSD-II) Date: 2005-12-22 Interventions: Biological: Myozyme 20 mg/kg qow Other Name: algluco |
Completed |
Study Name: A Study of rhGAA in Patients With Late-Onset Pompe Disease Condition: Pompe Disease (Late-onset) Glycogen Storage Disease Type II (GSD-II) Date: 2005-11-08 Interventions: Biological: Myozyme 20 mg/kg qow Other Name: algluco |
Completed |
Study Name: IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency Condition: T-Cell Immune Deficiency Diseases Severe Combined Immunodeficie Date: 2005-09-27 Interventions: Drug: Busulfan, Fludarabine and ATG |
Completed |
Study Name: Relation Between Maternal Iodine Status and Prenatal Foetal Thyroid Dimension Condition: Deficiency Disease Date: 2005-09-10 Interventions: Other: echography Correlation of neonatal thyroid volume with maternal iodine deficiency |
Completed |
Study Name: A Placebo-Controlled Study of Safety and Effectiveness of Myozyme (Alglucosidase Alfa) in Patients With Late-Onset Pompe Disease Condition: Pompe Disease (Late-onset) Glycogen Storage Disease Type II (GSD-II) Date: 2005-09-08 Interventions: Biological: alglucosidase alfa |